Oscar Health (NYSE:OSCR) Hits New 12-Month High – Should You Buy?

Oscar Health, Inc. (NYSE:OSCR)’s share price hit a new 52-week high during mid-day trading on Monday . The stock traded as high as $26.06 and last traded at $26.5660, with a volume of 1727899 shares traded. The stock had previously closed at $24.51.

Analysts Set New Price Targets

Several brokerages recently issued reports on OSCR. Barclays increased their price target on shares of Oscar Health from $21.00 to $30.00 and gave the stock an “equal weight” rating in a research note on Tuesday, May 26th. Raymond James Financial upgraded shares of Oscar Health from a “market perform” rating to an “outperform” rating and set a $18.00 price target for the company in a research note on Thursday, February 12th. Weiss Ratings reiterated a “sell (d)” rating on shares of Oscar Health in a research note on Tuesday, April 21st. Robert W. Baird increased their price target on shares of Oscar Health from $15.00 to $19.00 and gave the stock a “neutral” rating in a research note on Thursday, May 7th. Finally, Wall Street Zen lowered shares of Oscar Health from a “strong-buy” rating to a “buy” rating in a research note on Saturday. Two analysts have rated the stock with a Buy rating, nine have issued a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, Oscar Health has a consensus rating of “Hold” and an average target price of $20.22.

Oscar Health Trading Down 0.9%

The stock’s fifty day moving average price is $19.02 and its 200 day moving average price is $16.25. The company has a quick ratio of 1.11, a current ratio of 1.11 and a debt-to-equity ratio of 0.26. The stock has a market cap of $8.19 billion, a PE ratio of -46.02, a PEG ratio of 1.92 and a beta of 2.37.

Oscar Health (NYSE:OSCR) last posted its quarterly earnings results on Wednesday, May 6th. The company reported $2.07 EPS for the quarter, beating analysts’ consensus estimates of $1.11 by $0.96. Oscar Health had a negative net margin of 0.30% and a negative return on equity of 3.26%. The firm had revenue of $4.65 billion for the quarter, compared to analysts’ expectations of $4.90 billion. During the same quarter in the prior year, the company posted $0.92 earnings per share. The business’s revenue for the quarter was up 52.6% on a year-over-year basis. On average, sell-side analysts forecast that Oscar Health, Inc. will post 0.47 EPS for the current year.

Insider Activity at Oscar Health

In other Oscar Health news, insider Janet Liang sold 12,475 shares of the business’s stock in a transaction dated Tuesday, June 2nd. The stock was sold at an average price of $21.94, for a total value of $273,701.50. Following the completion of the transaction, the insider owned 259,057 shares of the company’s stock, valued at approximately $5,683,710.58. The trade was a 4.59% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Mario Schlosser sold 34,120 shares of the company’s stock in a transaction dated Tuesday, June 2nd. The shares were sold at an average price of $21.94, for a total transaction of $748,592.80. Following the transaction, the director owned 480,866 shares in the company, valued at $10,550,200.04. This represents a 6.63% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders sold a total of 189,660 shares of company stock valued at $4,283,140 over the last three months. 25.11% of the stock is owned by insiders.

Institutional Trading of Oscar Health

A number of institutional investors have recently made changes to their positions in the stock. Vanguard Group Inc. boosted its holdings in shares of Oscar Health by 2.7% during the 4th quarter. Vanguard Group Inc. now owns 20,701,250 shares of the company’s stock valued at $297,477,000 after acquiring an additional 540,851 shares during the last quarter. T. Rowe Price Investment Management Inc. boosted its holdings in shares of Oscar Health by 11.0% during the 4th quarter. T. Rowe Price Investment Management Inc. now owns 9,217,816 shares of the company’s stock valued at $132,461,000 after acquiring an additional 910,320 shares during the last quarter. Morgan Stanley boosted its holdings in shares of Oscar Health by 42.8% during the 4th quarter. Morgan Stanley now owns 6,814,046 shares of the company’s stock valued at $97,918,000 after acquiring an additional 2,043,758 shares during the last quarter. Thrive Capital Management LLC boosted its holdings in shares of Oscar Health by 33.4% during the 4th quarter. Thrive Capital Management LLC now owns 6,343,617 shares of the company’s stock valued at $85,258,000 after acquiring an additional 1,588,395 shares during the last quarter. Finally, BIT Capital GmbH boosted its holdings in shares of Oscar Health by 545.0% during the 4th quarter. BIT Capital GmbH now owns 6,186,267 shares of the company’s stock valued at $88,897,000 after acquiring an additional 5,227,152 shares during the last quarter. Hedge funds and other institutional investors own 75.70% of the company’s stock.

About Oscar Health

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company’s primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.